CLEVELAND – Hormone therapy is commonly combined with radiation therapy for prostate cancer, but patients are often unsure how long it should be ...
SurvivorNet on MSN
Cancer patients are living longer — a closer look at the treatments driving this progress
New data show cancer survival has reached a record high — nearly 70% of patients now live at least five years after diagnosis ...
Join Tom and Mike as they share an important update on Tom's prostate cancer journey. In this video, they discuss Tom's ...
Cartoonist Scott Adams died at 68 after a prolonged battle with prostate cancer. To know what its symptoms, causes, ...
It Ends With Us author Colleen Hoover recently shared insight into her treatment journey amid her cancer diagnosis: "Second ...
Medicus Pharma Ltd. (Nasdaq: MDCX) is a precision guided biotech/life sciences company focused on accelerating the clinical development programs of novel and potentially disruptive therapeutics assets ...
The disease was projected to account for 30 per cent of all new cancers among men nationwide. Cancer diagnoses among younger ...
The novel MEK inhibitor atebimetinib in combination with modified gemcitabine/nab-paclitaxel led to a 12-month overall ...
Investigators sought to evaluate changes in the estimated CV risk of men with prostate cancer after 6 months of hormone therapy using clinical tools established for the general population. A post-hoc ...
A new study published in Nature Communications provides a framework for researching whether earlier, model-guided treatment ...
A former prostate cancer patient who got the all-clear said taking part in a trial that cut his radiotherapy treatments ...
-- Curium's Investigational New Drug (IND) application for 177Lu-PSMA-I&T, a therapeutic agent for patients with metastatic castration-resistant prostate cancer (mCRPC), has been accepted by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback